Literature DB >> 16554542

Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.

Annemiek A van der Eijk, Jan Maarten Vrolijk, Bart L Haagmans.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16554542     DOI: 10.1056/NEJMc052880

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Expression of biologically active human interferon alpha 2b in the milk of transgenic mice.

Authors:  Hui Li; Qingyou Liu; Kuiqing Cui; Jinfeng Liu; Yanping Ren; Deshun Shi
Journal:  Transgenic Res       Date:  2012-06-03       Impact factor: 2.788

2.  Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity.

Authors:  Peng Zhang; Fang Sun; Caroline Tsao; Sijun Liu; Priyesh Jain; Andrew Sinclair; Hsiang-Chieh Hung; Tao Bai; Kan Wu; Shaoyi Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

3.  The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration.

Authors:  Weiwei Aileen Li; Beverly Ying Lu; Luo Gu; Youngjin Choi; Jaeyun Kim; David J Mooney
Journal:  Biomaterials       Date:  2016-01-11       Impact factor: 12.479

4.  Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?

Authors:  Valerie Touitou; Damien Sene; Christine Fardeau; Thi-Huong-Du Boutin; Pierre Duhaut; Jean-Charles Piette; Phuc LeHoang; Patrice Cacoub; Bahram Bodaghi
Journal:  Int Ophthalmol       Date:  2007-02-23       Impact factor: 2.029

5.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13

6.  Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells.

Authors:  Martin Loignon; Sylvie Perret; John Kelly; Denise Boulais; Brian Cass; Louis Bisson; Fatemeh Afkhamizarreh; Yves Durocher
Journal:  BMC Biotechnol       Date:  2008-08-27       Impact factor: 2.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.